Status:
COMPLETED
Comparison between2 Drugs in Lupus Nephritis
Lead Sponsor:
Al-Azhar University
Conditions:
Lupus Nephritis
Eligibility:
FEMALE
20-50 years
Phase:
PHASE4
Brief Summary
The aim of this work is to study the effect and side effects of the cyclophosphamide versus mycophenolate in lupus nephritis
Detailed Description
Systemic lupus erythematosus (SLE), also known simply as lupus, is an autoimmune disease in which the body's immune system mistakenly attacks healthy tissue in many parts of the body. Symptoms vary b...
Eligibility Criteria
Inclusion
- All patients have systemic lupus erythromatosis with lupus nephritis either newly diagnosed or with history of SLE with lupus nephrits
- All stage of lupus nephritis except stage(i,v,vi)
- patients who accepted to participate in the study.
Exclusion
- Patient with acute inflammatory process such as(rheumatoid arthritis or other rhumatoligical diseases).
- Patients who are taking other immunosuppressive therapy.
- Patients with malignancies.
- Patients with HCV, HBV or HIV infection.
- Patients with lupus nephritis sage(i,v,vi).
Key Trial Info
Start Date :
April 5 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 9 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04424602
Start Date
April 5 2021
End Date
September 9 2021
Last Update
June 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ALAzhar university
Cairo, Egypt